GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Buyback Yield %

OSTX (OS Therapies) Buyback Yield % : -14.27 (As of Apr. 22, 2025)


View and export this data going back to 2024. Start your Free Trial

What is OS Therapies Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

OS Therapies's current buyback yield was -14.27%.

OS Therapies Buyback Yield % Historical Data

The historical data trend for OS Therapies's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OS Therapies Buyback Yield % Chart

OS Therapies Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Buyback Yield %
- - - -5.85

OS Therapies Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -5.85

Competitive Comparison of OS Therapies's Buyback Yield %

For the Biotechnology subindustry, OS Therapies's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OS Therapies's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OS Therapies's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where OS Therapies's Buyback Yield % falls into.


;
;

OS Therapies Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

OS Therapies's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 5.226) / 89.3236
=-5.85%

OS Therapies's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 5.226) / 89.3236
=-5.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

OS Therapies Buyback Yield % Related Terms

Thank you for viewing the detailed overview of OS Therapies's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

OS Therapies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OS Therapies Inc (AMEX:OSTX) » Definitions » Buyback Yield %
Comparable Companies
KPTI ALXO RNXT SRZN INKT CVKD FBLG KZR NRXP LVTX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
115 Pullman Crossing Road, Suite 103, Grasonville, MD, USA, 21638
Website
https://www.ostherapies.com
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.